Space technology against leg pathologies and vessel diseases

The Vacumed is the latest development and innovative top technology from WEYERGANS HIGH CARE MEDICAL.

Between 8 to 22 percent of the population have a peripheral occlusive arterial disease (OAD) according to a report from the 22nd European Cardiology Congress, Amsterdam. And the tendency is rising! Seven percent of patients have to undergo an amputation within five years; this risk is increased to as much as 30 percent for diabetics. Due to the high cardiovascular risk not only the extremities but also the lives of the patients are in danger. So great significance should be attached to therapy and prevention.

Here it is - the treatment method you and a lot of your patients have been waiting for for years. Intermittent lower body negative pressure therapy with the VACUMED device represents innovation and state of the art technology in the battle against leg and vascular diseases. The principle of the VACUMED lies in space medicine. No astronaut can do without the lower body negative pressure device (LBNPD) in manned space travel in order to keep fit in the weightlessness of space and maintain the arterial blood supply of the lower extremities. Numerous tests carried out by NASA and the German Space Agency verify drastic capillary dilation and capillarisation together with an increase in micro and macroperfusion in the lower extremities even with continual application with negative pressure.

Further information about the vacumed you will find here:www.vacumed.de